Recurrent hyperglycemia during adalimumab treatment in a patient with psoriasis
Journal
Archives of Dermatology
Journal Volume
144
Journal Issue
10
Pages
1403-1404
Date Issued
2008
Author(s)
Wu J.-J.
SDGs
Other Subjects
acarbose; adalimumab; cyclosporin; efalizumab; etanercept; etretin; glimepiride; glucose; infliximab; metformin; methotrexate; tumor necrosis factor; adult; case report; diabetes mellitus; diabetic patient; disease course; disease exacerbation; drug substitution; drug withdrawal; glucose blood level; human; hyperglycemia; hypoglycemia; infection; injection site reaction; letter; liver toxicity; male; monotherapy; pancreas islet beta cell; pancreas islet cell function; photochemotherapy; priority journal; psoriasis; recurrent disease; rheumatoid arthritis; side effect; skin disease; treatment outcome; unspecified side effect; Adult; Antibodies, Monoclonal; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Hyperglycemia; Psoriasis; Recurrence; Risk Assessment; Sulfonylurea Compounds; Tumor Necrosis Factor-alpha
Type
letter